Insulet wins $452 mln US verdict against EOFlow in insulin pump secrets case https://t.co/qPHMHbiQWq https://t.co/eh30J2Hbs0
BREAKING: A federal jury has awarded Massachusetts-based Insulet Corp. $452 million after concluding that a South Korean company stole its trade secrets for a wearable insulin patch pump, marking one of the largest trade secrets verdicts of the decade. https://t.co/OfcS5GgLcH https://t.co/nAznb9vMmr
Insulet Successfully Defends its Intellectual Property Against EOFlow Co. in U.S. District Court https://t.co/FnwM0EdzOW https://t.co/aTXWusJHgp
Insulet Corporation, a Massachusetts-based medical device company, has successfully defended its intellectual property in a U.S. District Court case against EOFlow Co., a South Korean company. A federal jury awarded Insulet $452 million after determining that EOFlow had misappropriated trade secrets related to Insulet's wearable insulin patch pump technology. This verdict is considered one of the largest trade secrets awards in recent years, highlighting the significant financial and legal stakes in the medical device industry.